article_metadata: Shibin Zhu Chenhao Yu Chongwei Wang Guoqing Ding Sheng Cheng
article_metadata: 10.3389/fonc.2022.969106
article_metadata: Front Oncol
article_metadata: 2022 Oct 18;12:969106.
article_metadata: immune checkpoint inhibitor pseudoprogression renal pelvic urothelial carcinoma sarcomatoid carcinoma differentiation tislelizumab tyrosine kinase inhibitor upper tract urothelial carcinoma
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/36330483/
article_metadata: Case Reports
article_metadata: PMC9623047
article_metadata: 36330483
article_metadata: Case report: Significant benefits of tislelizumab combined with anlotinib in first-line treatment of metastatic renal pelvic urothelial carcinoma with sarcomatoid carcinoma differentiation
article_metadata: 2022